Progress Towards PBM Reform: Insights, Political Considerations, and Outlook for 2024-2025 | ArentFox Schiff

As we predicted at the end of the 117th Congress, 2023 was a year of progress for advocates of Pharmacy Benefit Manager (PBM) reform. Abusive practices by PBMs received...

Related Keywords

Cathy Mcmorris Rodgers ,Arentfox Schiff ,Us Department Of Justice Antitrust Division ,Senate Finance ,Members Of Congress ,Biden Administration ,Senate Finance Committee ,House Oversight Committee ,Republican Study Committee ,Pension Committee ,Better Mental Health Care ,Senate Finance Subcommittee On Healthcare ,Senate Health ,Commerce Committee ,House Ways Means Health Subcommittee ,House Energy ,House Appropriations Committee ,Energy Commerce ,Commerce Health Subcommittee Ranking Member ,Pharmacy Benefit Manager ,Lower Costs ,More Transparency Act ,Senate Finance Committee Chair Ron Wyden ,Finance Subcommittee ,Healthcare Chair Ben Cardin ,Senate Special Committee ,Aging Ranking Member Mike Braun ,Aging Committee ,Joe Manchin ,Commerce Committee Chair Cathy Mcmorris ,Anna Eshoo ,Commerce Health Subcommittee Ranking ,Michael Burgess ,Larry Buchson ,Kay Granger ,House Appropriations ,Lisa Blunt Rochester ,Jim Banks ,House Education ,Republican Study ,Brad Wenstrup ,House Ways ,Means Health Subcommittee ,Federal Trade Commission ,Antitrust Division ,Lower Cost Drugs ,Extenders Act ,Delinking Revenue ,Unfair Gouging ,Neighborhood Options ,Patients Buying Medicines Act ,House Oversight ,Means Committees ,Pharmacy Benefit Manager Reform Act ,